Insider Selling: Stryker (NYSE:SYK) VP Sells $1,394,417.28 in Stock

Stryker Corporation (NYSE:SYK) VP Robert Fletcher sold 4,544 shares of the business’s stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $306.87, for a total transaction of $1,394,417.28. Following the completion of the sale, the vice president directly owned 10,582 shares of the company’s stock, valued at approximately $3,247,298.34. This trade represents a 30.04% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Stryker Price Performance

Shares of SYK opened at $305.73 on Monday. Stryker Corporation has a 1-year low of $281.00 and a 1-year high of $404.87. The stock has a market cap of $117.21 billion, a PE ratio of 35.39, a price-to-earnings-growth ratio of 1.92 and a beta of 0.78. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.11 and a quick ratio of 1.25. The firm has a fifty day moving average price of $321.82 and a 200 day moving average price of $348.10.

Stryker (NYSE:SYK) last announced its quarterly earnings results on Thursday, April 30th. The medical technology company reported $2.60 earnings per share for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). Stryker had a net margin of 13.20% and a return on equity of 23.42%. The company had revenue of $6.02 billion during the quarter, compared to analysts’ expectations of $6.34 billion. During the same period last year, the firm earned $2.84 earnings per share. Stryker’s revenue was up 2.6% on a year-over-year basis. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. As a group, sell-side analysts anticipate that Stryker Corporation will post 14.98 EPS for the current year.

Stryker Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be issued a dividend of $0.88 per share. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $3.52 annualized dividend and a dividend yield of 1.2%. Stryker’s dividend payout ratio (DPR) is currently 40.74%.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in SYK. Godfrey Financial Associates Inc. purchased a new position in Stryker during the fourth quarter worth about $26,000. Sankala Group LLC purchased a new position in Stryker in the fourth quarter valued at about $26,000. United Financial Planning Group LLC purchased a new position in Stryker in the third quarter valued at about $27,000. Atlas Capital Advisors Inc. purchased a new position in Stryker in the fourth quarter valued at about $27,000. Finally, DJE Kapital AG purchased a new position in Stryker in the fourth quarter valued at about $28,000. 77.09% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

SYK has been the subject of several recent research reports. Needham & Company LLC decreased their price target on Stryker from $454.00 to $418.00 and set a “buy” rating for the company in a report on Friday, May 1st. The Goldman Sachs Group reissued a “neutral” rating and set a $361.00 price target on shares of Stryker in a report on Friday, May 1st. Barclays cut their price target on shares of Stryker from $469.00 to $394.00 and set an “overweight” rating for the company in a report on Monday, May 4th. JPMorgan Chase & Co. cut their price target on shares of Stryker from $445.00 to $400.00 and set an “overweight” rating for the company in a report on Friday, May 1st. Finally, Deutsche Bank Aktiengesellschaft set a $315.00 price target on shares of Stryker in a report on Friday, May 1st. Sixteen equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $395.48.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.